EHAB · As filed with the SEC
Enhabit balance sheet, by quarter
The statement as Enhabit presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Balance Sheets · USD
| USD | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | 50,000,000 | 43,600,000 | 56,900,000 | 37,100,000 | 39,500,000 | 28,400,000 | 45,700,000 | 28,500,000 |
| Restricted cash | 1,500,000 | 1,900,000 | 2,000,000 | 1,800,000 | 1,300,000 | 1,900,000 | 1,700,000 | 1,700,000 |
| Accounts receivable, net of allowances | 154,400,000 | 144,000,000 | 148,700,000 | 158,500,000 | 160,900,000 | 149,200,000 | 150,900,000 | 166,000,000 |
| Prepaid expenses and other current assets | 13,300,000 | 16,100,000 | 6,100,000 | 8,100,000 | 9,600,000 | 13,200,000 | 9,900,000 | 10,600,000 |
| Total current assets | 219,200,000 | 205,600,000 | 213,700,000 | 205,500,000 | 211,300,000 | 192,700,000 | 208,200,000 | 206,800,000 |
| Property and equipment, net | 16,700,000 | 15,500,000 | 16,100,000 | 16,200,000 | 16,100,000 | 17,700,000 | 19,400,000 | 21,600,000 |
| Operating lease right-of-use assets | 49,700,000 | 49,800,000 | 50,800,000 | 51,700,000 | 52,100,000 | 52,800,000 | 54,300,000 | 55,000,000 |
| Goodwill | 855,300,000 | 855,300,000 | 900,000,000 | 900,000,000 | 900,000,000 | 900,000,000 | 953,800,000 | 1,061,700,000 |
| Intangible assets, net | 35,100,000 | 38,500,000 | 45,200,000 | 49,400,000 | 53,600,000 | 58,100,000 | 63,900,000 | 69,000,000 |
| Other long-term assets | 2,900,000 | 2,400,000 | 2,500,000 | 2,600,000 | 2,800,000 | 4,700,000 | 4,700,000 | 4,900,000 |
| Total assets | 1,178,900,000 | 1,167,100,000 | 1,228,300,000 | 1,225,400,000 | 1,235,900,000 | 1,226,000,000 | 1,304,300,000 | 1,419,000,000 |
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Current portion of long-term debt | 26,000,000 | 22,300,000 | 22,300,000 | 22,400,000 | 22,500,000 | 22,800,000 | 23,000,000 | 23,000,000 |
| Current operating lease liabilities | 12,500,000 | 12,600,000 | 12,900,000 | 12,900,000 | 12,800,000 | 12,300,000 | 11,700,000 | 11,000,000 |
| Accounts payable | 8,600,000 | 9,200,000 | 7,200,000 | 11,500,000 | 8,000,000 | 6,700,000 | 9,900,000 | 8,500,000 |
| Accrued payroll | 50,900,000 | 40,400,000 | 49,300,000 | 36,600,000 | 49,400,000 | 37,100,000 | 47,100,000 | 37,000,000 |
| Refunds due patients and other third-party payers | — | — | — | — | — | 5,400,000 | 4,100,000 | 10,400,000 |
| Accrued medical insurance | — | — | — | 7,600,000 | 7,800,000 | 5,500,000 | 8,500,000 | 9,800,000 |
| Other current liabilities | 42,200,000 | 41,800,000 | 43,800,000 | 39,900,000 | 41,000,000 | 36,400,000 | 38,600,000 | 40,400,000 |
| Total current liabilities | 140,200,000 | 126,300,000 | 135,500,000 | 130,900,000 | 141,500,000 | 126,200,000 | 142,900,000 | 140,100,000 |
| Long-term debt, net of current portion | 402,600,000 | 426,000,000 | 441,500,000 | 456,900,000 | 467,300,000 | 492,600,000 | 502,900,000 | 512,700,000 |
| Long-term operating lease liabilities, net of current portion | 39,000,000 | 39,100,000 | 39,800,000 | 40,600,000 | 41,000,000 | 41,800,000 | 43,400,000 | 44,300,000 |
| Deferred income tax liabilities | 13,200,000 | 11,500,000 | 14,200,000 | 14,100,000 | 12,800,000 | 11,500,000 | 17,100,000 | 16,400,000 |
| Other long-term liabilities | 0 | 100,000 | — | — | — | 0 | 100,000 | 100,000 |
| Total liabilities | 595,000,000 | 603,000,000 | 631,000,000 | 642,500,000 | 662,600,000 | 672,100,000 | 706,400,000 | 713,600,000 |
| Redeemable noncontrolling interests | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| Stockholders’ equity: | ||||||||
| Preferred stock, $0.10 par value; 1,500,000 shares authorized; no shares issued | — | 0 | — | — | — | 0 | — | — |
| Common stock, $0.01 par value; 200,000,000 shares authorized; 51,195,035 and 50,589,768 shares issued; and 50,723,245 and 50,369,917 shares outstanding as of December 31, 2025 and 2024, respectively | — | 500,000 | — | — | — | 500,000 | — | — |
| Capital in excess of par value | — | 443,600,000 | — | — | — | 426,600,000 | — | — |
| Accumulated other comprehensive loss | — | 0 | — | — | — | (200,000) | — | — |
| Retained earnings | — | 93,700,000 | — | — | — | 98,300,000 | — | — |
| Treasury stock, at cost, 471,790 and $219,851 shares as of December 31, 2025 and 2024, respectively | — | (3,800,000) | — | — | — | (1,700,000) | — | — |
| Total Enhabit, Inc. stockholders’ equity | 553,500,000 | 534,000,000 | 566,800,000 | 552,400,000 | 543,200,000 | 523,500,000 | 566,100,000 | 674,300,000 |
| Noncontrolling interests | 25,400,000 | 25,100,000 | 25,500,000 | 25,500,000 | 25,100,000 | 25,400,000 | 26,800,000 | 26,100,000 |
| Total stockholders’ equity | 578,900,000 | 559,100,000 | 592,300,000 | 577,900,000 | 568,300,000 | 548,900,000 | 592,900,000 | 700,400,000 |
| Total liabilities and stockholders’ equity | 1,178,900,000 | 1,167,100,000 | 1,228,300,000 | 1,225,400,000 | 1,235,900,000 | 1,226,000,000 | 1,304,300,000 | 1,419,000,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.